Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck

NCT00184028 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Insufficient Accrual

Conditions

Carcinoma of the Head and Neck

Interventions

DRUG: Taxotere
DRUG: Oxaliplatin

Sponsor

University of Southern California

Collaborators

[object Object]